Optime Care, a Specialty Pharmacy and Patient Services Organization, Recognizes the Critical Role of Pharmacists During American Pharmacist Month, October 2022

Optime Care, a national specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, expresses its appreciation for the valuable work performed by the nation’s pharmacists and supports American Pharmacists Month. This is an opportunity to acknowledge and highlight the critical role that pharmacists play in serving rare disease communities across the country.

“Pharmacists are a key resource for patients -- an integral component of the patient journey who fundamentally contribute to advancing favorable outcomes,” says Brandon Salke, Pharm.D., general manager and pharmacist-in-charge, Optime Care, who was recently named Specialty Pharmacist of the Year in the 2022 Next-Generation Pharmacist Awards. “Our specialty pharmacists and care coordinators utilize their deep rare disease expertise and dedication to continuously support patients throughout their treatment journey so they can achieve the best possible clinical outcomes.”

Optime Care pharmacists help ensure patients stay compliant to therapy with custom clinical programs. Optime Care pharmacists have the clinical skills, expertise and specialized experience to better manage patients with rare and orphan diseases. Most importantly, they have the clinical and communication skills necessary to make personal connections and optimize the patient journey.

Salke also points to the work of Optime Care’s patient care coordinators who provide a level of expertise to assist with insurance coverage, address financial needs and identify financial assistance programs to improve patient access to therapies.

“The role of pharmacists is evolving and expanding,” asserts Salke, citing the role of Optime Care’s patient-first distribution and patient management programs that allow specialty pharmacists to create deeper connections, offer more personalized care and enhance clinical outcomes of patients with rare and orphan diseases. “The adoption of telehealth solutions is another touchpoint for customized care and can foster discussions between patient and pharmacist. It is an opportunity to incorporate assessments and predetermined therapy inventions so the care team can monitor side-effects and gather data on therapy, adverse reactions and patients’ well-being.”

About Optime Care

Optime Care, Inc. is a nationally recognized specialty pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our executive team has partnered in launching and managing over 40 orphan products and programs while consistently implementing the best brand services for the community. Our experience with small patient populations and our strategic partnership with AscellaHealth, 2022 NASP Strategic Channel Partner, enhances our services and ability to serve the specialty pharmacy market. Optime Care has dual accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with a specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers. https://www.optimecare.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20221011005216/en/